{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:13:02Z","timestamp":1777885982768,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013770","name":"Beihua University","doi-asserted-by":"publisher","award":["2024021"],"award-info":[{"award-number":["2024021"]}],"id":[{"id":"10.13039\/501100013770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013770","name":"Beihua University","doi-asserted-by":"publisher","award":["2024066"],"award-info":[{"award-number":["2024066"]}],"id":[{"id":"10.13039\/501100013770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS194"],"award-info":[{"award-number":["YDZJ202201ZYTS194"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20210402015GH"],"award-info":[{"award-number":["20210402015GH"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cyto.2024.156828","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T04:51:14Z","timestamp":1733719874000},"page":"156828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prognostic value and clinical significance of IL-33 expression in patients with uterine corpus endometrial carcinoma"],"prefix":"10.1016","volume":"185","author":[{"given":"Yuqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinlong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZiShen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2024.156828_bb0005","first-page":"2464","article-title":"Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis[J]","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.cyto.2024.156828_bb0010","first-page":"12","article-title":"Cancer statistics, 2024[J]","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.cyto.2024.156828_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073794","article-title":"Rare subtype of endometrial Cancer: undifferentiated\/dedifferentiated endometrial carcinoma, from genetic aspects to clinical practice[J]","volume":"23","author":"Tung","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156828_bb0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40615-016-0292-2","article-title":"Endometrial Cancer trends by race and histology in the USA: projecting the number of new cases from 2015 to 2040[J]","volume":"4","author":"Gaber","year":"2017","journal-title":"J. Racial Ethn. Health Disparities."},{"issue":"4","key":"10.1016\/j.cyto.2024.156828_bb0025","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.18632\/aging.102817","article-title":"Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer[J]","volume":"12","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cyto.2024.156828_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102609","article-title":"MELK promotes endometrial carcinoma progression via activating mTOR signaling pathway[J]","volume":"51","author":"Xu","year":"2020","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.cyto.2024.156828_bb0035","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.7150\/jca.33720","article-title":"Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with type I endometrial carcinoma[J]","volume":"11","author":"Liang","year":"2020","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2024.156828_bb0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/gyno.1995.1210","article-title":"Endometrial carcinoma in elderly women[J]","volume":"58","author":"Hoffman","year":"1995","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156828_bb0045","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/er.2018-00242","article-title":"Endometriosis[J]","volume":"40","author":"Bulun","year":"2019","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.cyto.2024.156828_bb0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J]","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2024.156828_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity[J]","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2024.156828_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156015","article-title":"IL-33\/ST2 axis in autoimmune disease[J]","volume":"158","author":"Shakerian","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156828_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","article-title":"Emerging functions of IL-33 in homeostasis and immunity[J]","volume":"40","author":"Dwyer","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156828_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000492885","article-title":"Therapeutic strategies for targeting IL-33\/ST2 Signalling for the treatment of inflammatory diseases[J]","volume":"49","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cyto.2024.156828_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155961","article-title":"IL-33 biology in cancer: an update and future perspectives[J]","volume":"157","author":"Yeoh","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2024.156828_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9262919","article-title":"Clinical significance of serum Interleukin-31 and Interleukin-33 levels in patients of endometrial Cancer: a case control study[J]","volume":"2016","author":"Zeng","year":"2016","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.cyto.2024.156828_bb0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nbt.3772","article-title":"Toil enables reproducible, open source, big biomedical data analyses[J]","volume":"35","author":"Vivian","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cyto.2024.156828_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1471-2105-12-213","article-title":"Identifier mapping performance for integrating transcriptomics and proteomics experimental results[J]","volume":"12","author":"Day","year":"2011","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.cyto.2024.156828_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1471-2105-14-223","article-title":"A decision theory paradigm for evaluating identifier mapping and filtering methods using data integration[J]","volume":"14","author":"Day","year":"2013","journal-title":"BMC Bioinform."},{"issue":"12","key":"10.1016\/j.cyto.2024.156828_bb0100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"Database issue","key":"10.1016\/j.cyto.2024.156828_bb0105","doi-asserted-by":"crossref","first-page":"D412","DOI":"10.1093\/nar\/gkn760","article-title":"STRING 8--a global view on proteins and their functional interactions in 630 organisms[J]","volume":"37","author":"Jensen","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.cyto.2024.156828_bb0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters[J]","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"issue":"43","key":"10.1016\/j.cyto.2024.156828_bb0115","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles[J]","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cyto.2024.156828_bb0120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer[J]","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156828_bb0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data[J]","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinform."},{"issue":"2","key":"10.1016\/j.cyto.2024.156828_bb0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA Pan-Cancer clinical data resource to drive high-quality survival outcome analytics[J]","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.cyto.2024.156828_bb0135","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"Circlize implements and enhances circular visualization in R[J]","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.cyto.2024.156828_bb0140","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ijc.31961","article-title":"Risk factors for endometrial cancer: an umbrella review of the literature[J]","volume":"145","author":"Raglan","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"21","key":"10.1016\/j.cyto.2024.156828_bb0145","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial Cancer[J]","volume":"383","author":"Lu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cyto.2024.156828_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/his.12053","article-title":"Molecular pathology of endometrial carcinoma[J]","volume":"62","author":"Matias-Guiu","year":"2013","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.cyto.2024.156828_bb0155","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1200\/JCO.21.01874","article-title":"Pembrolizumab in patients with microsatellite instability-high advanced endometrial Cancer: results from the KEYNOTE-158 study[J]","volume":"40","author":"O\u2019malley","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2024.156828_bb0160","article-title":"Relationship between prognosis, immune infiltration level, and differential expression of PARVG gene in uterine Corpus endometrial carcinoma[J]","volume":"2022","author":"Wang","year":"2022","journal-title":"Contrast Media Mol. Imaging"},{"issue":"11","key":"10.1016\/j.cyto.2024.156828_bb0165","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.18632\/aging.205899","article-title":"Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma[J]","volume":"16","author":"Jiang","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"16","key":"10.1016\/j.cyto.2024.156828_bb0170","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/pros.23058","article-title":"Expression of IL-17A, E, and F and their receptors in human prostatic cancer: comparison with benign prostatic hyperplasia[J]","volume":"75","author":"Liu","year":"2015","journal-title":"Prostate"},{"issue":"13","key":"10.1016\/j.cyto.2024.156828_bb0175","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/cncr.25858","article-title":"Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival[J]","volume":"117","author":"Li","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.cyto.2024.156828_bb0180","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/CMAR.S236374","article-title":"Knocking out SST gene of BGC823 gastric Cancer cell by CRISPR\/Cas9 enhances migration, invasion and expression of SEMA5A and KLF2[J]","volume":"12","author":"Chen","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"12","key":"10.1016\/j.cyto.2024.156828_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24129962","article-title":"Neuropeptide Y peptide family and Cancer: antitumor therapeutic strategies[J]","volume":"24","author":"S\u00e1nchez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156828_bb0190","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ebiom.2018.10.034","article-title":"P53, GHRH, inflammation and cancer[J]","volume":"37","author":"Barabutis","year":"2018","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.cyto.2024.156828_bb0195","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1177\/0300060518819382","article-title":"Galanin expression is down-regulated in patients with gastric cancer[J]","volume":"47","author":"Zhang","year":"2019","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156828_bb0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13046-018-0833-0","article-title":"Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells[J]","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2024.156828_bb0205","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2147\/JHC.S450479","article-title":"PVALB was identified as an independent prognostic factor for HCC closely related to immunity, and its absence accelerates tumor progression by regulating NK cell infiltration[J]","volume":"11","author":"Gong","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"10.1016\/j.cyto.2024.156828_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100660","article-title":"Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer[J]","volume":"45","author":"Zhou","year":"2021","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.cyto.2024.156828_bb0215","first-page":"1","article-title":"Novel targets and their functions in the prognosis of uterine corpus endometrial cancer patients[J]","author":"Sui","year":"2024","journal-title":"J. Appl. Genet."},{"issue":"8","key":"10.1016\/j.cyto.2024.156828_bb0220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy[J]","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.cyto.2024.156828_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2019.03.002","article-title":"T-memory cells against cancer: remembering the enemy[J]","volume":"338","author":"Sarkar","year":"2019","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156828_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061692","article-title":"Frenemies in the microenvironment: harnessing mast cells for Cancer immunotherapy[J]","volume":"15","author":"Sulsenti","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.cyto.2024.156828_bb0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1574892808666131118232656","article-title":"Potential roles of eosinophils in cancer therapy: epidemiological studies, experimental models, and clinical pathology[J]","volume":"9","author":"Cao","year":"2014","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.cyto.2024.156828_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669992","article-title":"Epigenetic reprogramming of CD4(+) helper T cells as a strategy to improve anticancer immunotherapy[J]","volume":"12","author":"Renaude","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156828_bb0245","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00281-016-0596-7","article-title":"Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer[J]","volume":"39","author":"Watt","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156828_bb0250","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00812261","article-title":"Th1\/Th2 balance in cancer, transplantation and pregnancy[J]","volume":"21","author":"Shurin","year":"1999","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.cyto.2024.156828_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115976","article-title":"Polysaccharides regulate Th1\/Th2 balance: a new strategy for tumor immunotherapy[J]","volume":"170","author":"Shang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.cyto.2024.156828_bb0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.canlet.2013.03.002","article-title":"Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice[J]","volume":"335","author":"Gao","year":"2013","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.cyto.2024.156828_bb0265","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1111\/all.14965","article-title":"The TGF-\u03b2-Th2 axis: a new target for cancer therapy?[J]","volume":"76","author":"Garc\u00eda De Durango","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.cyto.2024.156828_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and regulation of T(H) cells: a balancing act for Cancer immunotherapy[J]","volume":"12","author":"Basu","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156828_bb0275","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease[J]","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2024.156828_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155891","article-title":"Interleukin-33 (IL-33): a critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine[J]","volume":"156","author":"Cayrol","year":"2022","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.cyto.2024.156828_bb0285","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ccell.2023.06.008","article-title":"A distinct stimulatory cDC1 subpopulation amplifies CD8(+) T cell responses in tumors for protective anti-cancer immunity[J]","volume":"41","author":"Meiser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cyto.2024.156828_bb0290","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12967-024-05134-6","article-title":"CD8(+) T cell-based cancer immunotherapy[J]","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.cyto.2024.156828_bb0295","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer-natural killer cell immunity cycle[J]","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.cyto.2024.156828_bb0300","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41590-022-01127-z","article-title":"Innate lymphoid cells and cancer[J]","volume":"23","author":"Jacquelot","year":"2022","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156828_bb0305","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41385-020-0320-8","article-title":"The interplay between innate lymphoid cells and T cells[J]","volume":"13","author":"Cherrier","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cyto.2024.156828_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103232","article-title":"Elevated type I IFN signalling directly affects CD8(+) T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients[J]","volume":"146","author":"Huang","year":"2024","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.cyto.2024.156828_bb0315","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00109-019-01865-y","article-title":"MicroRNA-181a regulates IFN-\u03b3 expression in effector CD8(+) T cell differentiation[J]","volume":"98","author":"Amado","year":"2020","journal-title":"J. Mol. Med. (Berl)"},{"issue":"21","key":"10.1016\/j.cyto.2024.156828_bb0320","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1158\/1078-0432.CCR-16-0933","article-title":"Molecular pathways: targeting CD96 and TIGIT for Cancer immunotherapy[J]","volume":"22","author":"Blake","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156828_bb0325","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy[J]","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2024.156828_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103893","article-title":"A potential novel cancer immunotherapy: agonistic anti-CD40 antibodies[J]","volume":"29","author":"Jian","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"6960","key":"10.1016\/j.cyto.2024.156828_bb0335","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02055","article-title":"The DNA sequence and analysis of human chromosome 6[J]","volume":"425","author":"Mungall","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2024.156828_bb0340","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.imlet.2021.07.005","article-title":"HLA class II peptide-binding-region analysis reveals funneling of polymorphism in action[J]","volume":"238","author":"Sarri","year":"2021","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.cyto.2024.156828_bb0345","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cell.2018.08.048","article-title":"Evolutionary pressure against MHC class II binding Cancer mutations[J]","volume":"175","author":"Marty Pyke","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2024.156828_bb0350","article-title":"Immune and metabolic dysregulated coding and non-coding RNAs reveal survival Association in Uterine Corpus Endometrial Carcinoma[J]","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.cyto.2024.156828_bb0355","article-title":"Cancer-related triplets of mRNA-lncRNA-miRNA revealed by integrative network in uterine Corpus endometrial carcinoma[J]","volume":"2017","author":"Liu","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"10","key":"10.1016\/j.cyto.2024.156828_bb0360","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker[J]","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.cyto.2024.156828_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152025","article-title":"IL-33 synergistically promotes the proliferation of lung cancer cells in vitro by inducing antibacterial peptide LL-37 and proinflammatory cytokines in macrophages[J]","volume":"225","author":"Jiang","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.cyto.2024.156828_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156672","article-title":"IL-33-dependent NF-\u03baB activation inhibits apoptosis and drives chemoresistance in acute myeloid leukemia[J]","volume":"180","author":"Yan","year":"2024","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cyto.2024.156828_bb0375","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12032-016-0782-4","article-title":"The role of IL-37 in cancer[J]","volume":"33","author":"Ding","year":"2016","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cyto.2024.156828_bb0380","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3389\/fimmu.2019.01197","article-title":"IL-1 family members in Cancer; two sides to every story[J]","volume":"10","author":"Baker","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156828_bb0385","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1684\/ecn.2023.0491","article-title":"Clinical significance of IL-37 serum level and polymorphism in patients with endometrial cancer[J]","volume":"34","author":"Haghshenas","year":"2023","journal-title":"Eur. Cytokine Netw."},{"issue":"6","key":"10.1016\/j.cyto.2024.156828_bb0390","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41374-021-00544-2","article-title":"IL-37b\u03941-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1\/NF-\u03baB\/MMP2 signal pathway[J]","volume":"101","author":"Wang","year":"2021","journal-title":"Lab. Investig."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624003326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624003326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:20:47Z","timestamp":1777605647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624003326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":78,"alternative-id":["S1043466624003326"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156828","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value and clinical significance of IL-33 expression in patients with uterine corpus endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156828"}}